CD8A and neoplasm: M-MDSCs promote immune escape by the inhibition of CD8+ T-cell infiltration into tumour tissues, depending on CCR2-mediated signalling [94] or suppression of CD8+ T-cell proliferation, including using CCR5-related pathway signalling [95].